These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33909462)

  • 1. Diagnostic Accuracy of MRI for the Detection of Malignant Peripheral Nerve Sheath Tumors: A Systematic Review and Meta-Analysis.
    Wilson MP; Katlariwala P; Low G; Murad MH; McInnes MDF; Jacques L; Jack AS
    AJR Am J Roentgenol; 2021 Jul; 217(1):31-39. PubMed ID: 33909462
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of magnetic resonance imaging in the diagnostic evaluation of malignant peripheral nerve sheath tumors.
    Chhabra A; Soldatos T; Durand DJ; Carrino JA; McCarthy EF; Belzberg AJ
    Indian J Cancer; 2011; 48(3):328-34. PubMed ID: 21921333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Ristow I; Madesta F; Well L; Shenas F; Wright F; Molwitz I; Farschtschi S; Bannas P; Adam G; Mautner VF; Werner R; Salamon J
    Neuro Oncol; 2022 Oct; 24(10):1790-1798. PubMed ID: 35426432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral nerve sheath tumor: differentiation of malignant from benign tumors with conventional and diffusion-weighted MRI.
    Yun JS; Lee MH; Lee SM; Lee JS; Kim HJ; Lee SJ; Chung HW; Lee SH; Shin MJ
    Eur Radiol; 2021 Mar; 31(3):1548-1557. PubMed ID: 32894357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant and Benign Peripheral Nerve Sheath Tumors in a Single Center: Value of Clinical and Ultrasound Features for the Diagnosis of Malignant Peripheral Nerve Sheath Tumor Compared With Magnetic Resonance Imaging.
    Jin Z; Wang C; Wang D; Li X; Guo W; Chen T
    J Ultrasound Med; 2024 Jan; 43(1):21-31. PubMed ID: 37772628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging cellularity in benign and malignant peripheral nerve sheath tumors: Utility of the "target sign" by diffusion weighted imaging.
    Ahlawat S; Fayad LM
    Eur J Radiol; 2018 May; 102():195-201. PubMed ID: 29685535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI.
    Ristow I; Kaul MG; Stark M; Zapf A; Riedel C; Lenz A; Mautner VF; Farschtschi S; Apostolova I; Adam G; Bannas P; Salamon J; Well L
    Neurooncol Adv; 2024; 6(1):vdae021. PubMed ID: 38468867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of CT and MR features for detecting atypical lipomatous tumors and malignant liposarcomas: a systematic review and meta-analysis.
    Wilson MP; Haidey J; Murad MH; Sept L; Low G
    Eur Radiol; 2023 Dec; 33(12):8605-8616. PubMed ID: 37439933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging.
    Well L; Salamon J; Kaul MG; Farschtschi S; Herrmann J; Geier KI; Hagel C; Bockhorn M; Bannas P; Adam G; Mautner VF; Derlin T
    Neuro Oncol; 2019 Mar; 21(4):508-516. PubMed ID: 30496452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Quality of Magnetic Resonance Imaging Interpretation for Peripheral Nerve Sheath Tumors: Can Malignancy Be Determined?
    Karsy M; Guan J; Ravindra VM; Stilwill S; Mahan MA
    J Neurol Surg A Cent Eur Neurosurg; 2016 Nov; 77(6):495-504. PubMed ID: 27276118
    [No Abstract]   [Full Text] [Related]  

  • 11. Magnetic Resonance Imaging Features for Differentiating Low-Grade and High-Grade Malignant Peripheral Nerve Sheath Tumors.
    Yamada N; Kato H; Kawaguchi M; Suzui N; Miyazaki T; Nagano A; Noda Y; Hyodo F; Matsuo M
    J Comput Assist Tomogr; 2024 May-Jun 01; 48(3):436-442. PubMed ID: 38083833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis.
    Martin E; Geitenbeek RTJ; Coert JH; Hanff DF; Graven LH; Grünhagen DJ; Verhoef C; Taal W
    Neuro Oncol; 2021 Apr; 23(4):557-571. PubMed ID: 33326583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology of the entering and exiting nerve as a differentiating feature of benign from malignant peripheral nerve sheath tumours of the brachial plexus.
    Pressney I; Khoo M; Khan R; Abernethy P; Hargunani R; Saifuddin A
    Skeletal Radiol; 2021 Aug; 50(8):1557-1565. PubMed ID: 33410965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
    Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
    Salamon J; Mautner VF; Adam G; Derlin T
    Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
    Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
    Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Classification of Peripheral Nerve Sheath Tumors on MRI Using Radiomics.
    Jansma CYMN; Wan X; Acem I; Spaanderman DJ; Visser JJ; Hanff D; Taal W; Verhoef C; Klein S; Martin E; Starmans MPA
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
    Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
    Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Ahlawat S; Blakeley JO; Rodriguez FJ; Fayad LM
    Neurology; 2019 Sep; 93(11):e1076-e1084. PubMed ID: 31395668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
    Chirindel A; Chaudhry M; Blakeley JO; Wahl R
    J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.